Brigitta-Maria Liechty

Title: Brigitta-Maria Liechty: Innovator in Cyclic Depsipeptides

Introduction

Brigitta-Maria Liechty is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of cyclic depsipeptides, with a focus on their applications in medical treatments. Her innovative work has led to the development of several patents that address critical health issues.

Latest Patents

Brigitta-Maria Liechty holds 3 patents related to cyclic depsipeptides. Her latest patents include formulations that relate to cyclic depsipeptides, or derivatives thereof, which serve as inhibitors of kallikrein 7 and human neutrophil elastase. One of her notable patents discusses the use of cyclic depsipeptides to inhibit kallikrein 7, which can be employed for the treatment of kallikrein-7 dependent diseases.

Career Highlights

Brigitta-Maria Liechty is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to explore the therapeutic potential of cyclic depsipeptides, contributing to advancements in medical science.

Collaborations

Throughout her career, Brigitta-Maria has collaborated with esteemed colleagues such as Philipp Krastel and Esther Schmitt. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Brigitta-Maria Liechty's contributions to the field of cyclic depsipeptides exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a key figure in the development of new therapeutic solutions.